Editorial · 31 Aug 2023
Mini reviewPublished 28 Apr 2023
By Preventing -Glucosidase and -Amylase Noncompetitively, Phenols from Sterculia Nobilis Smith Pericarp In-Products Postpone the Digestion of Carbohydrates
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The functional activity and phytochemical makeup of Sterculia Nobilis Smith pericarp, a byproduct of this tropical and subtropical fruit, have not received much attention. The LC-ESIMS/MS-MRM technique was employed in this study to analyse 16 phenolic compounds in the ethyl acetate fraction of the Sterculia Nobilis Smith pericarp extract on a qualitative and quantitative level. The main phenolic in the EAF were luteolin-7-O-glucoside, epicatechin gallate, and apigetrin. Models of inhibition of -glucosidase and -amylase were used to investigate the hypoglycemic action of EAF. With half-inhibitory concentration levels, EAF inhibited -glucosidase and -amylase activities in a reversible and non-competitive manner. The EAF's enzyme inhibition mechanism was investigated using spectroscopic techniques. The outcomes demonstrated that EAF changed the secondary structure and microenvironment of the enzymes' tyrosine and tryptophan residues. This study shows that the pericarp of Sterculia Nobilis Smith can be used as a low-cost raw material for the manufacturing of functional meals. Internal organ damage brought on by hyperglycemia can result in heart attacks, kidney failure, stroke, blindness, and kidney failure. As a result, diabetes has grown to be a serious hazard to human health and must be treated with long-term usage of hypoglycemic medications. These medications do have negative effects, though; include weight gain, upper respiratory tract infections, hypoglycemia, and gastrointestinal issues. Keywords Sterculia Nobilis Smith Pericarp; Phenolics; A-Glucosidase; A-Amylase; Postprandial Hyperglycemia
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Molecular Enzymology and Drug Targets.
Editorial · 31 Aug 2023
Beyond the Norm: Unraveling Non-competitive Inhibition in Enzyme Kinetics and Drug Development
Editorial · 31 Aug 2023
Targeting the Achilles Heel: Cancer Drug Targets for Precision Therapies
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMolecular Enzymology and Drug Targets
- SubjectBiochemistry & Biotechnology
- SubjectGenetics & Molecular Biology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Pooja Bhatiya”
